|
Website:
http://www.bms.com
Phone: +1 212 546-4000 |
Address:
345 Park Avenue
New York, NEW YORK 10154 |
Company Description
Bristol-Myers Squibb Company. The Group's principal activities are to produce and distribute pharmaceuticals and other healthcare related products. The Group operates in three reportable segments: Pharmaceuticals, Nutritionals and Other Healthcare. Pharmaceuticals segment manufactures, distributes and sells branded pharmaceuticals. Nutritionals segment manufactures, markets, distributes and sells infant formulas and other nutritional products, including the entire line of ENFAMIL products. Other Healthcare segment consists of ConvaTec, Medical Imaging and Consumer Medicines. ConvaTec manufactures, distributes and sells ostomy, modern wound and skin care products. Medical Imaging manufactures, distributes and sells cardiovascular imaging products. Consumer Medicines manufactures, distributes and sells health care products. The Group operates in the United States, France, Japan, Germany, Spain, Italy and Canada. Pharmaceuticals accounted for 77% of 2006 revenues; Nutritionals, 13% and Other Healthcare, 10%
Key People
| Chairman | James D. Robinson III |
| Chief Executive Officer | James M. Cornelius |
| Executive Vice President & Chief Financial Officer | Andrew R.J. Bonfield |
| Vice President Finance & Controller | David L. Zabor |
| Senior Vice President, Secretary & General Counsel | Sandra Leung |
Related Business Topics
1-9 |
A |
B |
C |
D |
E |
F |
G |
H |
I |
J |
K |
L |
M |
N |
O |
P |
Q |
R |
S |
T |
U |
V |
W |
X |
Y |
Z
B
Breaking News
Reuters - 9 hours ago
PARIS, Nov 12 (Reuters) - Below are leading stories from French newspapers and company-related news which could have an impact on the French market or individual stocks. SANOFI-AVENTIS (SASY.PA: Quote, Profile, Research, Stock Buzz) The blood pressure ...
CNBC - 16 hours ago
CHICAGO, Nov 11 (Reuters) - Popular heartburn drugs increase the risk of heart attack or stroke when taken together with the widely prescribed blood thinner Plavix, according to a study released on Tuesday. Patients taking proton pump inhibitors such as ...
Reuters UK - 23 hours ago
NEW ORLEANS (Reuters) - Researchers have overestimated the ability to administer Eli Lilly and Co's experimental prasugrel blood thinner without causing dangerous bleeding, a prominent cardiologist said on Monday. U.S. regulators in recent months have ...
Forbes.com - December 01, 2008 2:16 AM
dom - * Glaxo to close Dartford manufacturing site in UK by 2013 * Closure to result in loss of 620 jobs * Decision reflects patent expiries and efficiency drive (Adds product details, background on industry job cuts) By Ben Hirschler LONDON, Nov 11 ...
Forbes.com - November 30, 2008 11:48 PM
By Ben Hirschler LONDON, Nov 11 (Reuters) - GlaxoSmithKline, the world's second biggest drugmaker, said on Tuesday it planned to close its Dartford manufacturing site in south-east England by 2013 with the loss of 620 jobs. The decision to close the ...
More Bristol-Myers News
Pharmaceutical MicroBio
Microbiology supplies for the Pharmaceutical Manufacturer
www.hardydiagnostics.com
Microbiology supplies for the Pharmaceutical Manufacturer
www.hardydiagnostics.com
